Takeda Pharmaceutical (TAK) FCF Margin (QoQ) (2018 - 2026)
Takeda Pharmaceutical (TAK) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.78 Bn | 42.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn |
| 3 | Zoetis | 31.66 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn |
| 6 | Viatris | 18.80 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Alkermes | 8.25 Bn | 7.59 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,967.00 |
| Mar 31, 2026 | -4,271.00 |
| Dec 31, 2025 | 2,605.00 |
| Sep 30, 2025 | -1,194.00 |
| Jun 30, 2025 | 3,461.00 |
| Mar 31, 2025 | -5,152.00 |
| Dec 31, 2024 | 3,134.00 |
| Sep 30, 2024 | -949.00 |
| Jun 30, 2024 | 2,115.00 |
| Mar 31, 2024 | -2,071.00 |
| Dec 31, 2023 | 1,105.00 |
| Sep 30, 2023 | -570.00 |
| Jun 30, 2023 | 852.00 |
| Mar 31, 2023 | -3,300.00 |
| Dec 31, 2022 | 1,257.00 |
| Sep 30, 2022 | 1,198.00 |
| Jun 30, 2022 | -394.00 |
| Mar 31, 2022 | -2,463.00 |
| Dec 31, 2021 | 1,032.00 |
| Sep 30, 2021 | 1,053.00 |